Sept. 20 (Bloomberg) -- Royal DSM NV, the world’s largest vitamin maker, said it’s in exclusive talks to buy Cargill Inc.’s cultures and enzymes business in an effort to gain a bigger share of a 1 billion-euro ($1.3 billion) market.
“A possible combination of the Cargill cultures and enzymes business with the dairy business of DSM Food Specialties would be highly complementary, creating a strong global player,” Heerlen, Netherlands-based DSM said in a statement today.
The Cargill division supplies the dairy and meat industries and has factories in Wisconsin and France, generating sales of about 45 million euros a year, DSM said. The acquisition would be the eighth by DSM’s nutrition unit since the Dutch company started transforming in 2010 from a commodity-chemical manufacturer into a maker of enzymes, specialty plastics and nutritional supplements, it said.
Industrywide demand for cultures and enzymes is growing steadily at more than 5 percent a year, DSM said.
To contact the reporter on this story: Maaike Noordhuis in Amsterdam at firstname.lastname@example.org
To contact the editor responsible for this story: Benedikt Kammel at email@example.com